Variant report

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr14:70567567..70570227-chr14:70598996..70601077,2	MCF-7	breast:

rSNPs within LD-proxies of this variant (count:31)

rs_ID	r²[population]
rs1009256	0.96[JPT][hapmap];0.86[ASN][1000 genomes]
rs10873226	0.95[JPT][hapmap];0.86[ASN][1000 genomes]
rs11158830	0.96[JPT][hapmap];0.86[ASN][1000 genomes]
rs11850085	0.95[JPT][hapmap];0.84[ASN][1000 genomes]
rs12586172	0.96[JPT][hapmap];0.86[ASN][1000 genomes]
rs12589441	0.95[JPT][hapmap];0.88[ASN][1000 genomes]
rs12590573	0.96[JPT][hapmap];0.86[ASN][1000 genomes]
rs12883784	0.95[JPT][hapmap];0.86[ASN][1000 genomes]
rs12883875	0.95[JPT][hapmap];0.86[ASN][1000 genomes]
rs12884186	0.95[JPT][hapmap];0.86[ASN][1000 genomes]
rs12888543	0.96[JPT][hapmap];0.86[ASN][1000 genomes]
rs12889279	0.96[JPT][hapmap];0.86[ASN][1000 genomes]
rs12890130	0.96[JPT][hapmap];0.86[ASN][1000 genomes]
rs149250	0.91[JPT][hapmap]
rs149595	0.82[ASN][1000 genomes]
rs150942	0.95[JPT][hapmap];0.84[ASN][1000 genomes]
rs150946	0.95[JPT][hapmap];0.82[ASN][1000 genomes]
rs17107768	0.95[JPT][hapmap];0.84[ASN][1000 genomes]
rs178921	0.96[JPT][hapmap];0.86[ASN][1000 genomes]
rs178923	0.81[ASN][1000 genomes]
rs1958184	0.96[JPT][hapmap];0.86[ASN][1000 genomes]
rs2169074	0.95[JPT][hapmap];0.86[ASN][1000 genomes]
rs4144997	0.96[JPT][hapmap];0.86[ASN][1000 genomes]
rs4899324	0.96[JPT][hapmap];0.85[ASN][1000 genomes]
rs4902775	0.84[ASN][1000 genomes]
rs4902776	0.81[CHB][hapmap];0.95[JPT][hapmap];0.86[ASN][1000 genomes]
rs6573922	0.95[JPT][hapmap];0.84[ASN][1000 genomes]
rs6573924	0.84[ASN][1000 genomes]
rs7161555	0.95[JPT][hapmap];0.86[ASN][1000 genomes]
rs8006790	0.81[ASN][1000 genomes]
rs8006924	0.96[JPT][hapmap];0.84[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:3 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv456336	chr14:70081956-70574149	Enhancers Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS Strong transcription Active TSS Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	75 gene(s)	inside rSNPs	diseases
2	nsv565007	chr14:70081956-70574149	Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Enhancers Strong transcription Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Active TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	75 gene(s)	inside rSNPs	diseases
3	nsv832826	chr14:70559589-70723464	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Strong transcription ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	5 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:8 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:70565800-70578400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
2	chr14:70565800-70578800	Weak transcription	Primary hematopoietic stem cells	blood
3	chr14:70566000-70578600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
4	chr14:70566400-70568600	Enhancers	Psoas Muscle	Psoas
5	chr14:70567600-70580800	Weak transcription	Skeletal Muscle Male	skeletal muscle
6	chr14:70567800-70568000	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
7	chr14:70567800-70568200	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
8	chr14:70567800-70582200	Weak transcription	Skeletal Muscle Female	skeletal muscle

Quick Search: